Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Consensus Recommendation of “Buy” by Analysts
Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) have earned a consensus rating of “Buy” from the six ratings firms that are presently covering the firm, Marketbeat reports. Five analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target […]
Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) have earned a consensus rating of “Buy” from the six ratings firms that are presently covering the firm, Marketbeat reports. Five analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target […]
